« FDA Approvals - Medical Devices Need Tracking After FDA Clearance, Senators SayMedical implants | Main | Price Chopper Supermarkets Issues Voluntary Cheesecake Recall December 20, 2011 »

FDA Approvals - Neuralstem's NSI-189 trial in major depressive disorder receives FDA approval


Neuralstem's NSI-189 trial in major depressive disorder receives FDA approval to advance to Phase Ib
( Neuralstem, Inc. ) Neuralstem's NSI-189 Neuroregenerative drug advances to Phase Ib in a major depressive disorder trial.
 

©2006 FDA-News.com. All rights reserved.